menu
    • menu

    Find Daclatasvir manufacturers, exporters & distributors on PharmaCompass

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Arlanda is your partner for the Brazil market.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-17

    Virtual Booth

    Contact Supplier

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass

    Synopsis

    Related ProductsRelated Products

    Synopsis

    ACTIVE PHARMA INGREDIENTS

    26

    API Suppliers

    API Suppliers

    5

    USDMF

    US DMFs Filed

    0

    CEP/COS

    CEP/COS Certifications

    0

    JDMF

    JDMFs Filed

    5

    EU WC

    EU WC

    0

    KDMF

    KDMF

    4

    NDC API

    NDC API

    0

    VMF

    NDC API

    21

    Listed Suppliers

    Other Suppliers

    7INTERMEDIATES

    REF. STANDARDS OR IMPURITIES

    0

    EDQM

    0

    USP

    0

    JP

    0

    Others

    FINISHED DOSAGE FORMULATIONS

    14

    FDF Dossiers

    FDF Dossiers

    3

    FDA Orange Book

    FDA (Orange Book)

    6

    Europe

    Europe

    0

    Canada

    Canada

    0

    Australia

    Australia

    0

    South Africa

    South Africa

    5

    Listed Dossiers

    Listed Dossiers

    0 DRUGS IN DEVELOPMENT

    FDF DossiersDRUG PRODUCT COMPOSITIONS

    128RELATED EXCIPIENT COMPANIES

    204EXCIPIENTS BY APPLICATIONS

    PATENTS & EXCLUSIVITIES

    18

    US Patents

    0

    US Exclusivities

    4

    Health Canada Patents

    API REF. PRICE (USD/KG)

    $
    $ 654

    GLOBAL SALES INFORMATION

    US Medicaid

    NA

    Annual Reports

    2,257

    Regulatory FDF Prices

    Listed Dossiers
    API/FDF Prices: Book a Demo to
    explore the features and consider
    upgrading later

    MARKET PLACE

    7

    API

    0

    FDF

    DIGITAL CONTENT

    0

    Data Compilation #PharmaFlow

    0

    Stock Recap #PipelineProspector

    0

    Weekly News Recap #Phispers

    44

    News #PharmaBuzz

    Chemistry

    Click the arrow to open the dropdown
    read-moreClick the button for full data set
    read-moreClick the button for full data set
    Also known as: 1009119-64-5, Daclatasvir (bms-790052), Bms-790052, Daklinza, 1214735-16-6, Ebp 883
    Molecular Formula
    C40H50N8O6
    Molecular Weight
    738.9  g/mol
    InChI Key
    FKRSSPOQAMALKA-CUPIEXAXSA-N
    FDA UNII
    LI2427F9CI
    Daclatasvir
    Daclatasvir is an orally available inhibitor of the hepatitis C virus (HCV) non-structural protein 5A (NS5A) replication complex, with potential activity against HCV. Although the exact mechanism of action of daclatasvir has yet to be fully determined, this agent, upon oral administration and after intracellular uptake, appears to bind to domain I of the NS5A protein. This inhibits the activity of the NS5A protein and results in the disruption of the viral RNA replication complex, blockage of viral HCV RNA production, and inhibition of viral replication. NS5A, a zinc-binding and proline-rich hydrophilic phosphoprotein, plays a crucial role in HCV RNA replication. HCV is a small, enveloped, single-stranded RNA virus belonging to the Flaviviridae family.
    Daclatasvir is a Hepatitis C Virus NS5A Inhibitor. The mechanism of action of daclatasvir is as a P-Glycoprotein Inhibitor, and Organic Anion Transporting Polypeptide 1B1 Inhibitor, and Organic Anion Transporting Polypeptide 1B3 Inhibitor, and Breast Cancer Resistance Protein Inhibitor.
    1 2D Structure

    Daclatasvir

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    methyl N-[(2S)-1-[(2S)-2-[5-[4-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate
    2.1.2 InChI
    InChI=1S/C40H50N8O6/c1-23(2)33(45-39(51)53-5)37(49)47-19-7-9-31(47)35-41-21-29(43-35)27-15-11-25(12-16-27)26-13-17-28(18-14-26)30-22-42-36(44-30)32-10-8-20-48(32)38(50)34(24(3)4)46-40(52)54-6/h11-18,21-24,31-34H,7-10,19-20H2,1-6H3,(H,41,43)(H,42,44)(H,45,51)(H,46,52)/t31-,32-,33-,34-/m0/s1
    2.1.3 InChI Key
    FKRSSPOQAMALKA-CUPIEXAXSA-N
    2.1.4 Canonical SMILES
    CC(C)C(C(=O)N1CCCC1C2=NC=C(N2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C(N5)C6CCCN6C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC
    2.1.5 Isomeric SMILES
    CC(C)[C@@H](C(=O)N1CCC[C@H]1C2=NC=C(N2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C(N5)[C@@H]6CCCN6C(=O)[C@H](C(C)C)NC(=O)OC)NC(=O)OC
    2.2 Other Identifiers
    2.2.1 UNII
    LI2427F9CI
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. Bms-790052

    2. Bms-790052-05

    3. Carbamic Acid, N,n'-((1,1'-biphenyl)-4,4'-diylbis(1h-imidazole-5,2-diyl-(2s)-2,1-pyrrolidinediyl((1s)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl)))bis-, C,c'-dimethyl Ester

    4. Daclatasvir Dihydrochloride

    5. Daklinza

    2.3.2 Depositor-Supplied Synonyms

    1. 1009119-64-5

    2. Daclatasvir (bms-790052)

    3. Bms-790052

    4. Daklinza

    5. 1214735-16-6

    6. Ebp 883

    7. Bms790052

    8. Bms 790052

    9. Daclatasvir [usan]

    10. Methyl N-[(2s)-1-[(2s)-2-[5-[4-[4-[2-[(2s)-1-[(2s)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1h-imidazol-5-yl]phenyl]phenyl]-1h-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate

    11. Chebi:82977

    12. Ebp-883

    13. Daclatasvir (usan)

    14. Carbamic Acid, N,n'-[[1,1'-biphenyl]-4,4'-diylbis[1h-imidazole-5,2-diyl-(2s)-2,1-pyrrolidinediyl[(1s)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]bis-, C,c'-dimethyl Ester

    15. Carbamic Acid, N,n'-((1,1'-biphenyl)-4,4'-diylbis(1h-imidazole-5,2-diyl-(2s)-2,1-pyrrolidinediyl((1s)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl)))bis-, C,c'-dimethyl Ester

    16. Dimethyl ((2s,2's)-((2s,2's)-2,2'-(5,5'-([1,1'-biphenyl]-4,4'-diyl)bis(1h-imidazole-5,2-diyl))bis(pyrrolidine-2,1-diyl))bis(3-methyl-1-oxobutane-2,1-diyl))dica

    17. 1009119-65-6

    18. Li2427f9ci

    19. Methyl N-[(1s)-1-[(2s)-2-[5-[4-[4-[2-[(2s)-1-[(2s)-2-(methoxycarbonylamino)-3-methyl-butanoyl]pyrrolidin-2-yl]-1h-imidazol-5-yl]phenyl]phenyl]-1h-imidazol-2-yl]pyrrolidine-1-carbonyl]-2-methyl-propyl]carbamate

    20. Daclatasvir [mi]

    21. Daclatasvir [inn]

    22. Daclatasvir [who-dd]

    23. Dimethyl (2s,2's)-1,1'-((2s,2's)-2,2'-(4,4'-(biphenyl-4,4'-diyl)bis(1h-imidazole-4,2-diyl))bis(pyrrolidine-2,1-diyl))bis(3-methyl-1-oxobutane-2,1-diyl)dicarbamate

    24. Mls006011140

    25. Ebp883

    26. Schembl2756027

    27. Chembl2023898

    28. Schembl17897804

    29. Gtpl11266

    30. Ex-a410

    31. Dtxsid901026404

    32. Amy36655

    33. Dimethyl ((2s,2's)-((2s,2's)-2,2'-(5,5'-([1,1'-biphenyl]-4,4'-diyl)bis(1h-imidazole-5,2-diyl))bis(pyrrolidine-2,1-diyl))bis(3-methyl-1-oxobutane-2,1-diyl))dicarbamate

    34. Dimethyl N,n'-(biphenyl-4,4'-diylbis{1h-imidazole-5,2-diyl-((2s)-pyrrolidine-2,1- Diyl)((1s)-1-(1-methylethyl)-2-oxoethane-2,1-diyl)})dicarbamate

    35. Bdbm50387084

    36. Mfcd17129086

    37. S1482

    38. Zinc68204830

    39. Ccg-270425

    40. Cs-0588

    41. Db09102

    42. Ncgc00346533-07

    43. Ncgc00346533-09

    44. Ac-28958

    45. As-75298

    46. Hy-10466

    47. Smr004702917

    48. Sw219754-1

    49. D10065

    50. J-520204

    51. Q5207712

    52. Dimethyl N,n'-((1,1'-biphenyl)-4,4'-diylbis(1h-imidazole-5,2-diyl-((2s)-pyrrolidine-2,1-diyl)((1s)-3-methyl-1-oxobutane-1,2-diyl)))dicarbamate

    53. Methyl ((s)-1-((s)-2-(5-(4'-(2-((s)-1-((methoxycarbonyl)-l-valyl)pyrrolidin-2-yl)-1h-imidazol-5-yl)-[1,1'-biphenyl]-4-yl)-1h-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate

    54. Methyl [(2s)-1-{(2s)-2-[4-(4'-{2-[(2s)-1-{(2s)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl}-2-pyrrolidinyl]-1h-imidazol-4-yl}-4-biphenylyl)-1h-imidazol-2-yl]-1-pyrrolidinyl}-3-methyl-1-oxo-2-butanyl]carbamate

    55. Methyl [(2s)-1-{(2s)-2-[4-(4'-{2-[(2s)-1-{(2s)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl}pyrrolidin-2-yl]-1h-imidazol-4-yl}biphenyl-4-yl)-1h-imidazol-2-yl]pyrrolidin-1-yl}-3-methyl-1-oxobutan-2-yl]carbamate

    56. Methyl [(2s)-1-{(2s)-2-[5-(4'-{2-[(2s)-1-{(2s)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl}pyrrolidin-2-yl]-1h-imidazol-5-yl}biphenyl-4-yl)-1h-imidazol-2-yl]pyrrolidin-1-yl}-3-methyl-1-oxobutan-2-yl]carbamate

    57. Methyl N-[(2s)-1-[(2s)-2-[5-(4'-{2-[(2s)-1-[(2s)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl]pyrrolidin-2-yl]-1h-imidazol-5-yl}-[1,1'-biphenyl]-4-yl)-1h-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate

    58. Methyl-n-[(2s)-1-[(2s)-2-[5-[4-[4-[2-[(2s)-1-[(2s)-2-(methoxycarbonylamino)-3-methylbutanoyl] Pyrrolidin-2-yl]-1h-imidazol-5-yl]phenyl]phenyl]-1himidazol-2-yl]pyrrolidin-1-yl]3-methyl-1-oxobutan-2-yl]carbamate

    2.4 Create Date
    2009-02-23
    3 Chemical and Physical Properties
    Molecular Weight 738.9 g/mol
    Molecular Formula C40H50N8O6
    XLogP35.1
    Hydrogen Bond Donor Count4
    Hydrogen Bond Acceptor Count8
    Rotatable Bond Count13
    Exact Mass738.38533134 g/mol
    Monoisotopic Mass738.38533134 g/mol
    Topological Polar Surface Area175 Ų
    Heavy Atom Count54
    Formal Charge0
    Complexity1190
    Isotope Atom Count0
    Defined Atom Stereocenter Count4
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Drug and Medication Information
    4.1 Drug Indication

    Indicated for use with sofosbuvir, with or without ribavirin, for the treatment of chronic HCV genotype 1a/b or 3 infection. The dosing regimen of 60mg daclatasvir 60 mg with 400mg sofosbuvir once a day is recommended for both genontypes. Resistance: Reduced susceptibility to daclatasvir was associated with the polymorphisms at NS5A amino acid positions M28, Q30, L31, and Y93 in genotypes 1a, 1b, and 3a patients. NS5A Resistance Testing is recommended for HCV genotype 1a-infected patients with cirrhosis prior to the initiaition of the treatment, as the risk of resistance development is higher in genotype 1a patients.

    FDA Label

    Daklinza is indicated in combination with other medicinal products for the treatment of chronic hepatitis C virus (HCV) infection in adults (see sections 4. 2, 4. 4 and 5. 1).

    For HCV genotype specific activity, see sections 4. 4 and 5. 1.

    5 Pharmacology and Biochemistry
    5.1 Pharmacology

    Daclatasvir is a direct-acting antiviral agent that targets the NS5A and causes a decrease in serum HCV RNA levels. It disrupts HCV replication by specifically inhibiting the critical functions of an NS5A protein in the replication complex. It is shown to cause downregulation of the hyperphosphorylation of NS5A. It does not appear to prolong the QT interval even when given at 3 times the maximum recommended dose.

    5.2 FDA Pharmacological Classification
    5.2.1 Active Moiety
    DACLATASVIR
    5.2.2 FDA UNII
    LI2427F9CI
    5.2.3 Pharmacological Classes
    Mechanisms of Action [MoA] - Breast Cancer Resistance Protein Inhibitors
    5.3 ATC Code

    J05AP07

    J - Antiinfectives for systemic use

    J05 - Antivirals for systemic use

    J05A - Direct acting antivirals

    J05AP - Antivirals for treatment of hcv infections

    J05AP07 - Daclatasvir

    5.4 Absorption, Distribution and Excretion

    Absorption

    Studies demonstrated that peak plasma concentrations typically occurred within 2 hours after administration of multiple oral doses ranging from 1 - 100 mg once daily. Steady state is reached after approximately 4 days of once-daily daclatasvir administration. The absolute bioavailability of the tablet formulation is 67%.

    Route of Elimination

    Approximately 88% of total dose of daclatasvir is eliminated into bile and feces in which 53% remains as unchanged form, while 6.6% of the total dose is eliminated primarily unchanged in the urine.

    Volume of Distribution

    The approximate volume of distribution of daclatasvir is 47 L in patients who was orally administered 60 mg tablet followed by 100 g [13C,15N]-daclatasvir intravenously.

    Clearance

    In subjects who received daclatasvir 60 mg tablet orally followed by 100 g radiolabeled daclatasvir intravenously, the total clearance was 4.2 L/h.

    5.5 Metabolism/Metabolites

    Daclastavir is a substrate of CYP3A enzymes where its metabolism is predominantly mediated by CYP3A4 isoform. Oxidative pathways included -oxidation of the pyrrolidine moiety, resulting in ring opening to an aminoaldehyde intermediate followed by an intramolecular reaction between the aldehyde and the proximal imidazole nitrogen atom. High proportion of the drug in the plasma (greater than 97%) is in the unchanged form.

    5.6 Biological Half-Life

    Following multiple dose administration of daclatasvir in HCV-infected subjects, with doses ranging from 1 mg to 100 mg once daily, the terminal elimination half-life of daclatasvir ranged from approximately 12 to 15 hours.

    5.7 Mechanism of Action

    NS5A is a viral nonstructural phospoprotein that is part of a functional replication complex in charge of viral RNA genome amplification on endoplasmic reticulum membranes. It has the ability to bind to HCV RNA. It is shown to have two distinct functions in HCV RNA replication based on phosphorylated states. Maintaining the HCV replication complex is mediated by the cis-acting function of basally phosphorylated NS5A and the trans-acting function of hyperphosphorylated NS5A modulates HCV assembly and infectious particle formation. Daclatasvir is shown to disrupt hyperphosphorylated NS5A proteins thus interfere with the function of new HCV replication complexes. It is also reported that daclatasvir also blocks both intracellular viral RNA synthesis and virion assembly/secretion in vivo.

    API SUPPLIERS

    read-more
    read-more

    01

    LGM Pharma

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    World ADC London
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothLGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Contact Supplier Contact Supplier
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    LGM Pharma CB

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Century Pharmaceuticals

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    iPHEX India
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothCentury has been an API manufacturer for over 40 years & is the partner of choice for multipurpose custom manufacturing projects.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    Century Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    HRV Global Life Sciences

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    DCAT Week
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothHRV Global Life Sciences - Market Expansion Leader in Pharmaceuticals.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    HRV Global Life Sciences

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    MSN Laboratories

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    World ADC London
    Not Confirmed
    arrow

    MSN Laboratories

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    World ADC London
    Not Confirmed
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 33496

    Submission : 2018-12-31

    Status : Active

    Type : II

     CEP/COS JDMF EU-WC NDC arrow-down
    ✖

    NDC Package Code : 69766-063

    Start Marketing Date : 2018-12-31

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

     KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Fuxin Long Rui Pharmaceutical

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    World ADC London
    Not Confirmed
    arrow

    Fuxin Long Rui Pharmaceutical

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    World ADC London
    Not Confirmed
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 33381

    Submission : 2018-12-19

    Status : Active

    Type : II

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Glenmark Life Sciences

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    World ADC London
    Not Confirmed
    arrow

    Glenmark Life Sciences

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    World ADC London
    Not Confirmed
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 32471

    Submission : 2018-03-29

    Status : Active

    Type : II

     CEP/COS JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2023-12-28

    Valid Till : 2026-12-28

    Written Confirmation Number : WC-0310

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 66039-941

    Start Marketing Date : 2018-03-29

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

     KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Hetero Drugs

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    World ADC London
    Not Confirmed
    arrow

    Hetero Drugs

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    World ADC London
    Not Confirmed
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2016-12-07

    Pay. Date : 2016-09-28

    DMF Number : 30975

    Submission : 2016-10-07

    Status : Active

    Type : II

     CEP/COS JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2022-09-16

    Valid Till : 2025-08-08

    Written Confirmation Number : WC-0041

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 68554-0094

    Start Marketing Date : 2015-07-24

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

     KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Cipla

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    World ADC London
    Not Confirmed
    arrow

    Cipla

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    World ADC London
    Not Confirmed
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 30737

    Submission : 2016-08-11

    Status : Inactive

    Type : II

     CEP/COS JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2022-06-17

    Valid Till : 2025-08-04

    Written Confirmation Number : WC-0142n

    Address of the Firm :

    NDC KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Laurus Labs

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    World ADC London
    Not Confirmed
    arrow

    Laurus Labs

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    World ADC London
    Not Confirmed
    USDMF CEP/COS JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2023-07-03

    Valid Till : 2025-07-02

    Written Confirmation Number : WC-0213

    Address of the Firm :

    NDC KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Farmak JSC

    Ukraine

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    PharmaVenue
    Attending
    arrow
    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Listed Suppliers

    read-more
    read-more

    01

    LGM Pharma

    U.S.A
    arrow
    World ADC London
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothLGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Contact Supplier Contact Supplier
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Daclatasvir

    About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, ...

    LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, analytical method development and testing, and commercial manufacturing. LGM Pharma offers custom API synthesis, analytical development, and regulatory services. With a network of over 300 accredited CGMP manufacturing partners, LGM provides unparalleled supply chain security. And, with over 100,000 square feet of FDA-inspected cGMP manufacturing and warehouse capacity, LGM Pharma provides a one-stop solution for solid dose, powder, semi-solid and liquid drugs.
    LGM Pharma CB

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Century Pharmaceuticals

    India
    arrow
    iPHEX India
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothCentury has been an API manufacturer for over 40 years & is the partner of choice for multipurpose custom manufacturing projects.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Daclatasvir

    About the Company : Century Pharmaceuticals, established in 1982, has 40 years of experience in manufacturing APIs. It has been supplying APIs produced in-house to several major pharma companies in In...

    Century Pharmaceuticals, established in 1982, has 40 years of experience in manufacturing APIs. It has been supplying APIs produced in-house to several major pharma companies in India and abroad. Its APIs are manufactured in accordance with cGMP, 21CFR part 10 and ICH guidelines. It also produces intermediates and develops new APIs as per the needs of its clients. Century conducts biotechnological research that focuses on human therapeutic proteins. Currently, research is underway to find treatments for asthma, mastocytosis and basophilic leukemia. Century supplies research-grade biotech products and a wide range of animal health products.
    Century Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    HRV Global Life Sciences

    India
    arrow
    DCAT Week
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothHRV Global Life Sciences - Market Expansion Leader in Pharmaceuticals.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Daclatasvir

    About the Company : HRV Global is a leading global manufacturer, seller & exporter of a wide range of APIs, advanced intermediates, pellets, food grade chemicals, food additives & food ingredients. It...

    HRV Global is a leading global manufacturer, seller & exporter of a wide range of APIs, advanced intermediates, pellets, food grade chemicals, food additives & food ingredients. It offers services such as sourcing, manufacturing & supply, helping partners enter new markets worldwide. Its strong partnerships with major players in the pharma and food additive industries help HRV Global effectively promote projects and products. HRV Global represents over 30 large Indian drugmakers, primarily targeting Europe, the US & the Middle East markets. Headquartered in India, HRV Global has offices in the US, Switzerland, Dubai, Lithuania & Turkey.
    HRV Global Life Sciences

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    CAD Middle East Pharmaceutical Indu...

    Saudi Arabia
    World ADC London
    Not Confirmed
    arrow

    CAD Middle East Pharmaceutical Indu...

    Saudi Arabia
    arrow
    World ADC London
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Saudi Arabia
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Daclatasvir dihydrochloride

    About the Company : CAD Middle East Pharmaceutical Industries LLC is a state-of-art manufacturing facility using latest technologies with dedication to manufacture the highest quality of Active Pharma...

    CAD Middle East Pharmaceutical Industries LLC is a state-of-art manufacturing facility using latest technologies with dedication to manufacture the highest quality of Active Pharmaceutical Ingredients (APIs) following current Good Manufacturing Practices (cGMP) standards. CAD Middle East Pharmaceutical Industries LLC established in Riyadh, Kingdom of Saudi Arabia. CAD manufacturing activities started in 2013. It is our guiding principle to introduce, through continuous research and development, consistent high quality following the latest GMP standards, low cost manufacturing of Innovative APIs for our diverse client base. We accomplish this by working in partnership with the clients/partners in understanding their current and future needs.
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Farmak JSC

    Ukraine
    arrow
    PharmaVenue
    Attending
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Ukraine
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    daclatasvir

    About the Company : Farmak International is a leading GMP EU certified pharmaceutical manufacturer in Ukraine established in 1925 with FDA inspected site for production of food supplement. Company spe...

    Farmak International is a leading GMP EU certified pharmaceutical manufacturer in Ukraine established in 1925 with FDA inspected site for production of food supplement. Company specialization is full-cycle production of finished dosage forms products for endocrinology, cardiology, rheumatology, ophthalmology and respiratory diseases; including anesthetics and radiopaque contrast media. Thanks to a strong research base and substantial investments in its production facilities, Farmak International possesses a considerable portfolio of high quality products and is open to cooperation, including but not limited to private labeling, in- and out-licensing, technologies transfers, R&D and contract manufacturing.
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Hangzhou Longshine Bio-Tech

    China
    World ADC London
    Not Confirmed
    arrow

    Hangzhou Longshine Bio-Tech

    China
    arrow
    World ADC London
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    daclatasvir

    About the Company : Established in 2011 and situated in Hangzhou, Zhejiang, China, Hangzhou Longshine Bio-Tech CO., Ltd is dedicated to providing services for pharmaceutical and chemical products, cat...

    Established in 2011 and situated in Hangzhou, Zhejiang, China, Hangzhou Longshine Bio-Tech CO., Ltd is dedicated to providing services for pharmaceutical and chemical products, catering to both export and import markets. The company consists of two primary business departments: the Professional Sourcing/Product Team and the Quality Team. Backed by experienced partners, Longshine has evolved into a trustworthy supplier of high-quality products and received ISO9001:2008 certification in 2017.
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Mangalam Drugs & Organics Ltd

    India
    World ADC London
    Not Confirmed
    arrow

    Mangalam Drugs & Organics Ltd

    India
    arrow
    World ADC London
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Daclatasvir

    About the Company : Mangalam Drugs & Organics Limited started manufacturing APIs and intermediates in 1977 in Gujarat, India. It has a multi-product manufacturing facility and an in-house R&D lab reco...

    Mangalam Drugs & Organics Limited started manufacturing APIs and intermediates in 1977 in Gujarat, India. It has a multi-product manufacturing facility and an in-house R&D lab recognized by the Department of Scientific and Industrial Research, India. Mangalam has established a reputation as a one-stop shop for anti-malaria API and its API manufacturing plant is approved by WHO-GENEVA GMP and EDQM. Mangalam has an agreement with the Clinton Health Access Initiative for the supply of anti-malaria APIs worldwide. It has a wide range of products and is the largest manufacturer of some products in the world. It is among the top companies in Asia.
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Optimus Pharma

    India
    World ADC London
    Not Confirmed
    arrow

    Optimus Pharma

    India
    arrow
    World ADC London
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Daclatasvir

    About the Company : Optimus is one of the fastest-growing pharmaceutical companies with 16 years of experience in providing the best quality of API, Intermediates & Finished formulations in Global mar...

    Optimus is one of the fastest-growing pharmaceutical companies with 16 years of experience in providing the best quality of API, Intermediates & Finished formulations in Global markets. Our aim from day one has been to provide and ensure better healthcare across the globe through our research, Innovations, affordable products & manufacturing excellence. Optimus was established to provide quality & affordable pharmaceutical products in the global markets.
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Synergene Active Ingredients Pvt Lt...

    India
    World ADC London
    Not Confirmed
    arrow

    Synergene Active Ingredients Pvt Lt...

    India
    arrow
    World ADC London
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    daclatasvir

    About the Company : Synergene Active Ingredients Pvt.Ltd was incorporated in 2006 and commercial operations began in the same year. The Company is a manufacturer and supplier of Active Pharmaceuticals...

    Synergene Active Ingredients Pvt.Ltd was incorporated in 2006 and commercial operations began in the same year. The Company is a manufacturer and supplier of Active Pharmaceuticals Ingredients (API'S) for wide range of therapeutic categories. Therapeutic segments of focus are Anti Fungals, Anti Depressants, and Anti Hypertensive. Synergene manufacturing facilities are cGMP compliant meeting global standards in terms of infrastructure and systems. The company has two manufacturing facilities located at Hyderabad & Vishakhapatnam manufacturing Active Pharmaceutical Ingredients and Intermediates.
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Viruj Pharmaceuticals Pvt Ltd

    India
    World ADC London
    Not Confirmed
    arrow

    Viruj Pharmaceuticals Pvt Ltd

    India
    arrow
    World ADC London
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Daclatasvir

    About the Company : Viruj Pharmaceuticals, an India-based company with a global presence, aims to develop & market complex, technology-driven APIs. It offers contract API manufacturing for innovative ...

    Viruj Pharmaceuticals, an India-based company with a global presence, aims to develop & market complex, technology-driven APIs. It offers contract API manufacturing for innovative companies globally, & APIs for generic companies. Viruj Pharmaceuticals adheres to quality systems defined in Schedule M, Schedule L, ICH Q7 & TRS guidelines & leads in process validation, cleaning validation, analytical method transfers & process technology. It ensures GMP compliance at its facility. Viruj seeks to develop APIs via continuous Flow Technology & has invested in the requisite infrastructure for developing APIs using Flow Chemistry techniques.
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    API Reference Price

    read-more
    read-more
    [{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1653503400,"product":"DACLATASVIR DIHYDROCHLORIDE IN-HOUSE","address":"H.NO.4-7-101, SCIENTIST COLONY, HABSIGUDA, NACHARAM, Contact No: 91","city":"HYDERABAD","supplier":"OPTIMUS DRUGS PRIVATE ","supplierCountry":"INDIA","foreign_port":"CAIRO","customer":"M\/S.TO THE ORDER OF","customerCountry":"EGYPT","quantity":"25.00","actualQuantity":"25","unit":"KGS","unitRateFc":"300","totalValueFC":"7310.5","currency":"USD","unitRateINR":22600,"date":"26-May-2022","totalValueINR":"565000","totalValueInUsd":"7310.5","indian_port":"HYDERABAD AIR","hs_no":"29349990","bill_no":"1660353","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"EGYPT","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"H.NO.4-7-101, SCIENTIST COLONY, HABSIGUDA, NACHARAM, Contact No: 91, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1678300200,"product":"DACLATASVIR DI HYDROCHLORIDE (TAX NO.VOL","address":"FLAT NO.202, RAJ APARTMENT,RAJEEV NAGAR","city":"HYDERABAD,TELANGANA","supplier":"VIRUPAKSHA ORGANICS","supplierCountry":"INDIA","foreign_port":"KARACHI -","customer":"MEDISURE LABORATORIES PAKISTAN","customerCountry":"PAKISTAN","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"650","totalValueFC":"559.3","currency":"USD","unitRateINR":46000,"date":"09-Mar-2023","totalValueINR":"46000","totalValueInUsd":"559.3","indian_port":"HYDERABAD AIR","hs_no":"29349990","bill_no":"8333824","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"PAKISTAN","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"FLAT NO.202, RAJ APARTMENT,RAJEEV NAGAR, HYDERABAD,TELANGANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q2","strtotime":1681151400,"product":"DACLATASVIR DI HYDROCHLORIDE","address":"B-4, IDA,","city":"HYDERABAD, TELANGANA.","supplier":"VIRUPAKSHA ORGANICS","supplierCountry":"INDIA","foreign_port":"ISLAMABAD","customer":"FERZSONS LABORATORIES LTD","customerCountry":"PAKISTAN","quantity":"32.00","actualQuantity":"32","unit":"KGS","unitRateFc":"433.8","totalValueFC":"13735.4","currency":"USD","unitRateINR":35177.125,"date":"11-Apr-2023","totalValueINR":"1125668","totalValueInUsd":"13735.4","indian_port":"ARSHIYA-SEZ\/PANVEL","hs_no":"29349990","bill_no":"4000663","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"PAKISTAN","selfForZScoreResived":"Pharma Grade","supplierPort":"ARSHIYA-SEZ\/PANVEL","supplierAddress":"B-4, IDA,, HYDERABAD, TELANGANA.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1689791400,"product":"DACLATASVIR DIHYDROCHLORIDE (TAX INV NO.","address":"FLAT NO.202, RAJ APARTMENT,RAJEEV NAGAR","city":"HYDERABAD,TELANGANA","supplier":"VIRUPAKSHA ORGANICS","supplierCountry":"INDIA","foreign_port":"ISLAMABAD - ISLAMABA","customer":"MCB BANK LIMITED","customerCountry":"PAKISTAN","quantity":"105.00","actualQuantity":"105","unit":"KGS","unitRateFc":"440","totalValueFC":"45468.1","currency":"USD","unitRateINR":35590.479599999999,"date":"20-Jul-2023","totalValueINR":"3737000.358","totalValueInUsd":"45468.1","indian_port":"HYDERABAD AIR","hs_no":"29332990","bill_no":"0","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"PAKISTAN","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"FLAT NO.202, RAJ APARTMENT,RAJEEV NAGAR, HYDERABAD,TELANGANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1696876200,"product":"DACLATASVIR DIHYDROCHLORIDE IN-HOUSE PHARMACEUTICAL FOR PHARMACEUTICAL RAW MATERIAL AS PER PO","address":"PLOT NO.131,3RD FLOOR,NARMADA","city":"HYDERABAD. AP","supplier":"OPTIMUS DRUGS PRIVATE ","supplierCountry":"INDIA","foreign_port":"CAIRO","customer":"TO THE ORDER OF","customerCountry":"EGYPT","quantity":"350.00","actualQuantity":"350","unit":"KGS","unitRateFc":"700","totalValueFC":"242198.4","currency":"USD","unitRateINR":57594.285714285717,"date":"10-Oct-2023","totalValueINR":"20158000","totalValueInUsd":"242198.4","indian_port":"Hyderabad Air","hs_no":"29349990","bill_no":"4528823","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"EGYPT","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PLOT NO.131,3RD FLOOR,NARMADA, HYDERABAD. AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1726857000,"product":"DACLATASVIR DIHYDROCHLORIDE TECHNICAL , CAS NO. 1009119-65-6, BATCH NOS. 41230924001 , 41230924002 MFG DATE S","address":"S. NO. 136\/11,,GAURA VADDO, CALANG","city":"CALANGUTE,GOA","supplier":"SADAR BIOTECH PRIVATE ","supplierCountry":"INDIA","foreign_port":"MOSCOW","customer":"TO THE ORDER","customerCountry":"RUSSIA","quantity":"129.00","actualQuantity":"129","unit":"KGS","unitRateFc":"99396","totalValueFC":"153005.9","currency":"INR","unitRateINR":99396.001705426359,"date":"21-Sep-2024","totalValueINR":"12822084.22","totalValueInUsd":"153005.9","indian_port":"Bombay Air","hs_no":"29420090","bill_no":"4235089","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"RUSSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"S. NO. 136\/11,,GAURA VADDO, CALANG, CALANGUTE,GOA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1727029800,"product":"DACLATASVIR DIHYDROCHLORIDE TECHNICAL","address":"S. NO. 136\/11,,GAURA VADDO, CALANG","city":"CALANGUTE,GOA","supplier":"SADAR BIOTECH PRIVATE ","supplierCountry":"INDIA","foreign_port":"MOSCOW","customer":"TO THE ORDER ,","customerCountry":"RUSSIA","quantity":"129.00","actualQuantity":"129","unit":"KGS","unitRateFc":"99396","totalValueFC":"153005.9","currency":"INR","unitRateINR":99396.001705426359,"date":"23-Sep-2024","totalValueINR":"12822084.22","totalValueInUsd":"153005.9","indian_port":"Bombay Air","hs_no":"29420090","bill_no":"4275880","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"RUSSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"S. NO. 136\/11,,GAURA VADDO, CALANG, CALANGUTE,GOA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1729794600,"product":"DACLATASVIR DIHYDROCHLORIDE","address":"FLAT.203,SATYA SAI RESY.PLOT","city":"ROAD,AMEERPET, HYDERABAD,AP","supplier":"NIFTY LABS","supplierCountry":"INDIA","foreign_port":"MOSCOW","customer":"M\/S.PHS-LEKSREDSTVA JSC","customerCountry":"RUSSIA","quantity":"2.00","actualQuantity":"2","unit":"KGS","unitRateFc":"900","totalValueFC":"1722.8","currency":"USD","unitRateINR":72380,"date":"25-Oct-2024","totalValueINR":"144760","totalValueInUsd":"1722.8","indian_port":"Hyderabad Air","hs_no":"29332990","bill_no":"5115776","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"RUSSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"FLAT.203,SATYA SAI RESY.PLOT, ROAD,AMEERPET, HYDERABAD,AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1730917800,"product":"DACLATASVIR DIHYDROCHLORIDE TECHNICAL (GST INVOICE NO:U1\/24-25\/EXP\/131 DT:31\/10\/2024)","address":"48,49,50,209,210 211.PHASE-II","city":"N\/A","supplier":"ARENE LIFE SCIENCES PRIVATE LIMITED","supplierCountry":"INDIA","foreign_port":"SHEREMETYEVO","customer":"JSC PHARMSTANDARD","customerCountry":"RUSSIA","quantity":"97.00","actualQuantity":"97","unit":"KGS","unitRateFc":"74000","totalValueFC":"78193","currency":"INR","unitRateINR":68026.420824742265,"date":"07-Nov-2024","totalValueINR":"6598562.82","totalValueInUsd":"78193","indian_port":"Hyderabad Air","hs_no":"29420090","bill_no":"5415801","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"RUSSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"48,49,50,209,210 211.PHASE-II, N\/A","customerAddress":""},{"dataSource":"API Import","activeIngredients":"DACLATASVIR DIHYDROCHLORIDE","year":"2021","qtr":"Q1","strtotime":1609439400,"product":"DACLATASVIR DIHYDROCHLORIDE","address":"26, MANOJ INDUSTRIAL ESTATE,G.D. AMBEKAR MARG, WADALA","city":"MUMBAI, MAHARASHTRA","supplier":"HANGZHOU YAXIN PHARMACEUTICAL ","supplierCountry":"CHINA","foreign_port":"SHANGHAI","customer":"FREDUN PHARMACEUTICALS LTD.","customerCountry":"INDIA","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"700","totalValueFC":"712.6","currency":"USD","unitRateINR":"52115","date":"01-Jan-2021","totalValueINR":"52115","totalValueInUsd":"712.6","indian_port":"BOMBAY AIR","hs_no":"29420090","bill_no":"2200067","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI","supplierAddress":"","customerAddress":"26, MANOJ INDUSTRIAL ESTATE,G.D. AMBEKAR MARG, WADALA"}]
    01-Jan-2021
    07-Nov-2024
    KGS
    overview
    Loading...

    Average Price (USD/KGS)

    Number of Transactions

    Total Quantity (KGS)

    Total Value (USD)

    Quantity (KGS) & Unit rate (USD/KGS) over time

    API/FDF Prices: Book a Demo to explore the features and consider upgrading later

    API Imports and Exports

    Importing Country Total Quantity
    (KGS)    		 Average Price
    (USD/KGS)    		 Number of Transactions

    Upgrade, download data, analyse, strategize, subscribe with us contact

    INTERMEDIATE SUPPLIERS

    read-more
    read-more

    01

    PMC Isochem

    France
    World ADC London
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothPMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Moc-Val-OH

    CAS Number : 74761-42-5

    End Use API : Daclatasvir

    About The Company : PMC Isochem is a CDMO company acquired by PMC International in 2017. It manufactures cGMP intermediates, active pharmaceutical ingredients and functional excipi...

    PMC Isochem

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Hangzhou Longshine Bio-Tech Co.,LTD

    China
    World ADC London
    Not Confirmed
    arrow

    Hangzhou Longshine Bio-Tech Co.,LTD

    China
    World ADC London
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    4, 4’-Bis (2-bromoacetyl) biphenyl

    CAS Number : 4072-67-7

    End Use API : Daclatasvir

    About The Company : Established in 2011 and situated in Hangzhou, Zhejiang, China, Hangzhou Longshine Bio-Tech CO., Ltd is dedicated to providing services for pharmaceutical and ch...

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Hangzhou Longshine Bio-Tech Co.,LTD

    China
    World ADC London
    Not Confirmed
    arrow

    Hangzhou Longshine Bio-Tech Co.,LTD

    China
    World ADC London
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    (S)-2-((Methoxycarbonyl)amino)-3-Methylbutanoic ac...

    CAS Number : 74761-42-5

    End Use API : Daclatasvir

    About The Company : Established in 2011 and situated in Hangzhou, Zhejiang, China, Hangzhou Longshine Bio-Tech CO., Ltd is dedicated to providing services for pharmaceutical and ch...

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Jiangsu Yutian Pharmaceutical Co., ...

    China
    World ADC London
    Not Confirmed
    arrow

    Jiangsu Yutian Pharmaceutical Co., ...

    China
    World ADC London
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    4,4'-Bis(2-bromoacetyl)biphenyl

    CAS Number : 4072-67-7

    End Use API : Daclatasvir

    About The Company : Jiangsu Yutian Pharmaceutical Co., Ltd. is located in Dapu Pharmaceutical Zone of Lianyungang City in Jiangsu Province. It is a new and high-tech enterprise eng...

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Jiangsu Yutian Pharmaceutical Co., ...

    China
    World ADC London
    Not Confirmed
    arrow

    Jiangsu Yutian Pharmaceutical Co., ...

    China
    World ADC London
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    1H-Imidazole, 5,5’-[1,1’-biphenyl]-4,4’-diyl...

    CAS Number : 1009119-83-8

    End Use API : Daclatasvir

    About The Company : Jiangsu Yutian Pharmaceutical Co., Ltd. is located in Dapu Pharmaceutical Zone of Lianyungang City in Jiangsu Province. It is a new and high-tech enterprise eng...

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Prajna Generics

    India
    World ADC London
    Not Confirmed
    arrow

    Prajna Generics

    India
    World ADC London
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    4,4'-Bis(2-bromoacetyl)biphenyl

    CAS Number : 4072-67-7

    End Use API : Daclatasvir

    About The Company : Prajna is an innovation driven pharmaceutical company. We dedicated to Research, Process development and Manufacturing APIs and Advanced Intermediates for Activ...

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Prajna Generics

    India
    World ADC London
    Not Confirmed
    arrow

    Prajna Generics

    India
    World ADC London
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    5,5’-[1,1’-Biphenyl]-4,4’-diylbis[2-(2S)-2- ...

    CAS Number : 1009119-83-8

    End Use API : Daclatasvir

    About The Company : Prajna is an innovation driven pharmaceutical company. We dedicated to Research, Process development and Manufacturing APIs and Advanced Intermediates for Activ...

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    FDF Dossiers

    read-more
    read-more

    01

    Bristol Myers Squibb

    U.S.A
    World ADC London
    Not Confirmed
    arrow

    Bristol Myers Squibb

    U.S.A
    arrow
    World ADC London
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    DACLATASVIR DIHYDROCHLORIDE

    Brand Name : DAKLINZA

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 60MG BASE

    Packaging :

    Approval Date : 2015-07-24

    Application Number : 206843

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Bristol Myers Squibb

    U.S.A
    World ADC London
    Not Confirmed
    arrow

    Bristol Myers Squibb

    U.S.A
    arrow
    World ADC London
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    DACLATASVIR DIHYDROCHLORIDE

    Brand Name : DAKLINZA

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 90MG BASE

    Packaging :

    Approval Date : 2016-04-13

    Application Number : 206843

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Bristol Myers Squibb

    U.S.A
    World ADC London
    Not Confirmed
    arrow

    Bristol Myers Squibb

    U.S.A
    arrow
    World ADC London
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : Sweden

    daklatasvirdihydroklorid

    Brand Name : Daklinza

    Dosage Form : FILM COATED PILL

    Dosage Strength : 30 MG

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Sweden

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Bristol Myers Squibb

    U.S.A
    World ADC London
    Not Confirmed
    arrow

    Bristol Myers Squibb

    U.S.A
    arrow
    World ADC London
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : Sweden

    daklatasvirdihydroklorid

    Brand Name : Daklinza

    Dosage Form : FILM COATED PILL

    Dosage Strength : 60 MG

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Sweden

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Bristol Myers Squibb

    U.S.A
    World ADC London
    Not Confirmed
    arrow

    Bristol Myers Squibb

    U.S.A
    arrow
    World ADC London
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : Italy

    daclatasvir

    Brand Name : Daklinza

    Dosage Form : Daclatasvir 30Mg 28 Combined Oral Use

    Dosage Strength : 28 cpr riv 30 mg

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Italy

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Bristol Myers Squibb

    U.S.A
    World ADC London
    Not Confirmed
    arrow

    Bristol Myers Squibb

    U.S.A
    arrow
    World ADC London
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : Italy

    daclatasvir

    Brand Name : Daklinza

    Dosage Form : Daclatasvir 60Mg 28 Combined Oral Use

    Dosage Strength : 28 cpr riv 60 mg

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Italy

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Bristol Myers Squibb

    U.S.A
    World ADC London
    Not Confirmed
    arrow

    Bristol Myers Squibb

    U.S.A
    arrow
    World ADC London
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : Norway

    daclatasvir

    Brand Name : Daklinza

    Dosage Form : Antic-calc Tablet, Film Coated

    Dosage Strength : 60 mg

    Packaging : Calendar Gasket

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Norway

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Cooper Pharma Limited

    India
    World ADC London
    Not Confirmed
    arrow

    Cooper Pharma Limited

    India
    arrow
    World ADC London
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : India

    Daclatasvir

    Brand Name :

    Dosage Form : Tablet

    Dosage Strength : 60MG

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : India

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    JV Pharmland

    Belarus
    World ADC London
    Not Confirmed
    arrow

    JV Pharmland

    Belarus
    arrow
    World ADC London
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Belarus
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : Belarus

    Daclatasvir

    Brand Name :

    Dosage Form : Tablet

    Dosage Strength : 60MG

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Belarus

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Orbit Lifescience

    India
    World ADC London
    Not Confirmed
    arrow

    Orbit Lifescience

    India
    arrow
    World ADC London
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : India

    Daclatasvir

    Brand Name : DACATEC

    Dosage Form : Tablet

    Dosage Strength : 60MG

    Packaging : Jar pack of 30's

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : India

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Listed Dossiers

    read-more
    read-more

    01

    Cooper Pharma Limited

    India
    World ADC London
    Not Confirmed
    arrow

    Cooper Pharma Limited

    India
    arrow
    World ADC London
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : India

    Daclatasvir

    Brand Name :

    Dosage Form : Tablet

    Dosage Strength : 60MG

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : India

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    01

    Cooper Pharma Limited

    India
    World ADC London
    Not Confirmed
    arrow

    Cooper Pharma Limited

    India
    arrow
    World ADC London
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Packaging :

    Regulatory Info :

    Daclatasvir

    Dosage : Tablet

    Dosage Strength : 60MG

    Brand Name :

    Approval Date :

    Application Number :

    Registration Country : India

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    JV Pharmland

    Belarus
    World ADC London
    Not Confirmed
    arrow

    JV Pharmland

    Belarus
    arrow
    World ADC London
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Belarus
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : Belarus

    Daclatasvir

    Brand Name :

    Dosage Form : Tablet

    Dosage Strength : 60MG

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Belarus

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    JV Pharmland

    Belarus
    World ADC London
    Not Confirmed
    arrow

    JV Pharmland

    Belarus
    arrow
    World ADC London
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Belarus
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Packaging :

    Regulatory Info :

    Daclatasvir

    Dosage : Tablet

    Dosage Strength : 60MG

    Brand Name :

    Approval Date :

    Application Number :

    Registration Country : Belarus

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Orbit Lifescience

    India
    World ADC London
    Not Confirmed
    arrow

    Orbit Lifescience

    India
    arrow
    World ADC London
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : India

    Daclatasvir

    Brand Name : DACATEC

    Dosage Form : Tablet

    Dosage Strength : 60MG

    Packaging : Jar pack of 30's

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : India

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Orbit Lifescience

    India
    World ADC London
    Not Confirmed
    arrow

    Orbit Lifescience

    India
    arrow
    World ADC London
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Packaging : Jar pack of 30's

    Regulatory Info :

    Daclatasvir

    Dosage : Tablet

    Dosage Strength : 60MG

    Brand Name : DACATEC

    Approval Date :

    Application Number :

    Registration Country : India

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Reliv Pharmaceutical

    Vietnam
    World ADC London
    Not Confirmed
    arrow

    Reliv Pharmaceutical

    Vietnam
    arrow
    World ADC London
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Vietnam
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : Vietnam

    Daclatasvir Dihydrochloride

    Brand Name : Zacutas 90

    Dosage Form : Tablet

    Dosage Strength : 98.88MG

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Vietnam

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Reliv Pharmaceutical

    Vietnam
    World ADC London
    Not Confirmed
    arrow

    Reliv Pharmaceutical

    Vietnam
    arrow
    World ADC London
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Vietnam
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Packaging :

    Regulatory Info :

    Daclatasvir Dihydrochloride

    Dosage : Tablet

    Dosage Strength : 98.88MG

    Brand Name : Zacutas 90

    Approval Date :

    Application Number :

    Registration Country : Vietnam

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Reliv Pharmaceutical

    Vietnam
    World ADC London
    Not Confirmed
    arrow

    Reliv Pharmaceutical

    Vietnam
    arrow
    World ADC London
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Vietnam
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : Vietnam

    Daclatasvir Dihydrochloride

    Brand Name : Zacutas 60

    Dosage Form : Tablet

    Dosage Strength : 65.92MG

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Vietnam

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Reliv Pharmaceutical

    Vietnam
    World ADC London
    Not Confirmed
    arrow

    Reliv Pharmaceutical

    Vietnam
    arrow
    World ADC London
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Vietnam
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Packaging :

    Regulatory Info :

    Daclatasvir Dihydrochloride

    Dosage : Tablet

    Dosage Strength : 65.92MG

    Brand Name : Zacutas 60

    Approval Date :

    Application Number :

    Registration Country : Vietnam

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    DRUG PRODUCT COMPOSITIONS

    Do you need Business Intel? Ask us

    DOSAGE - TABLET;ORAL - EQ 30MG BASE

    USFDA APPLICATION NUMBER - 206843

    read-more

    DOSAGE - TABLET;ORAL - EQ 60MG BASE

    USFDA APPLICATION NUMBER - 206843

    read-more

    DOSAGE - TABLET;ORAL - EQ 90MG BASE

    USFDA APPLICATION NUMBER - 206843

    read-more

    Related Excipient Companies

    Upload your portfolio for free, ask us

    Excipients by Applications

    Click here to find the perfect excipient manufacturers by their capabilities

    Coating Systems & Additives

    read-more
    read-more

    Fillers, Diluents & Binders

    read-more
    read-more

    Controlled & Modified Release

    read-more
    read-more

    Disintegrants & Superdisintegrants

    read-more
    read-more

    Thickeners and Stabilizers

    read-more
    read-more

    Direct Compression

    read-more
    read-more

    Granulation

    read-more
    read-more

    Lubricants & Glidants

    read-more
    read-more

    Film Formers & Plasticizers

    read-more
    read-more

    Co-Processed Excipients

    read-more
    read-more

    Rheology Modifiers

    read-more
    read-more

    Empty Capsules

    read-more
    read-more

    Vegetarian Capsules

    read-more
    read-more

    API Stability Enhancers

    read-more
    read-more

    Taste Masking

    read-more
    read-more

    Coloring Agents

    read-more
    read-more

    Emulsifying Agents

    read-more
    read-more

    Chewable & Orodispersible Aids

    read-more
    read-more

    Topical

    read-more
    read-more

    01

    Nanjing Well Pharmaceutical

    China
    arrow
    World ADC London
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothNanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Brand Name : Polyethylene Glycol 400

    Application : Fillers, Diluents & Binders, Film Formers & Plasticizers, Parenteral, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical

    Excipient Details : PEG 400 is used as a suspending agent, stabilizer, plasticizer and filler in OSDs, liquids & semi-solids and as a solvent for parenteral formulations.

    Pharmacopoeia Ref : ChP/USP/EP

    Technical Specs : NA

    Ingredient(s) : Polyethylene Glycol 400

    arrow
    Nanjing Well Polyethylene Glycol 400 NF

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    02

    Clariant

    Switzerland
    World ADC London
    Not Confirmed
    arrow

    03

    Finar

    India
    World ADC London
    Not Confirmed
    arrow

    04

    Actylis

    U.S.A
    World ADC London
    Not Confirmed
    arrow

    Surfactant & Foaming Agents

    read-more
    read-more

    Solubilizers

    read-more
    read-more

    Parenteral

    read-more
    read-more

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more

    Global Sales Information

    Do you need Business Intel? Ask us

    Market Place

    Do you need sourcing support? Ask us

    APIs

    read-more
    read-more
    india-flag.png
    Daclatasvir API needed in India [ENA20950]
    A company that focuses on marketing and distribution of various finished formulations is looking for suppliers of Daclatasvir API for commercial purposes. The suppliers must support this enquiry with DMF & CoA.
    25 Oct 2024

    Reply

    25 Oct 2024

    Reply text-arrow

    Reply Comment (4)

    25 Oct 2024

    india-flag.png
    Various APIs needed in India [ENA16469]
    A company that focuses on research, development and manufacturing of tablets, capsules, syrups, injections, ointments and dry powder is looking for suppliers of Various APIs for development purposes. The suppliers must support this enquiry with CoA. 1. Daclatasvir API 2. Pentasodium Triphosphate API 3. Potassium Nitrate API
    24 Feb 2023

    Reply

    24 Feb 2023

    Reply text-arrow

    Reply Comment (5)

    24 Feb 2023

    india-flag.png
    Various APIs needed in India [ENA13073]
    A company that deals in various pharmaceutical products like injections, syrups & hygiene products is looking for suppliers of Various APIs for commercial purpose. The suppliers must support this enquiry with CoA. 1. Daclatasvir (5 kg) API 2. Sofosbuvir (50 kg) API 3. Velpatasvir (25 kg) API
    23 Mar 2022

    Reply

    23 Mar 2022

    Reply text-arrow

    Reply Comment (5)

    23 Mar 2022

    United_States_of_America.png
    Clinical Grade Daclatasvir API needed in the United States [ENA10988]
    A company that deals in health care services including acute, specialty, primary and preventive care is looking for suppliers of Clinical Grade Daclatasvir API for human clinical trials.
    30 Jul 2021

    Reply

    30 Jul 2021

    Reply text-arrow

    Reply Comment (2)

    30 Jul 2021

    india-flag.png
    Sofosbuvir & Daclatasvir APIs needed in India [ENA08367]
    One of the leading contract manufacturers of pharmaceutical formulations that deal in tablets, capsules, ointment, syrups, lotion & injectables is looking for suppliers of Sofosbuvir & Daclatasvir APIs. The required quantity is MOQ for each.
    27 Aug 2020

    Reply

    27 Aug 2020

    Reply text-arrow

    Reply Comment (12)

    27 Aug 2020

    india-flag.png
    Daclatasvir (0.5 g) API needed in India [ENA08364]
    An integrated pharmaceutical company with core competencies in marketing and exporting of their own brands of various finished dosage formulations is looking for suppliers of Daclatasvir (0.5 g) API. The suppliers must support this enquiry with CoA.
    26 Aug 2020

    Reply

    26 Aug 2020

    Reply text-arrow

    Reply Comment (6)

    26 Aug 2020

    Brazil.png
    Daclatasvir (35 kg) API needed in Brazil [ENA07197]
    A pharmaceutical company that develops manufactures and commercializes medicines and active pharmaceutical ingredients is looking for suppliers of Daclatasvir (35 kg) API and its impurities. The suppliers must support this enquiry with CoA.
    01 May 2020

    Reply

    01 May 2020

    Reply text-arrow

    Reply Comment (17)

    01 May 2020

    PharmaCompass
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Patents & EXCLUSIVITIES

    Check the patents & exclusivity for this product

    ABOUT THIS PAGE

    Looking for 1009119-64-5 / Daclatasvir API manufacturers, exporters & distributors?

    Daclatasvir manufacturers, exporters & distributors 1

    64

    PharmaCompass offers a list of Daclatasvir API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Daclatasvir manufacturer or Daclatasvir supplier for your needs.

    Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Daclatasvir manufacturer or Daclatasvir supplier.

    PharmaCompass also assists you with knowing the Daclatasvir API Price utilized in the formulation of products. Daclatasvir API Price is not always fixed or binding as the Daclatasvir Price is obtained through a variety of data sources. The Daclatasvir Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

    API | Excipient name

    Daclatasvir

    Synonyms

    1009119-64-5, Daclatasvir (bms-790052), Bms-790052, Daklinza, 1214735-16-6, Ebp 883

    Cas Number

    1009119-64-5

    Unique Ingredient Identifier (UNII)

    LI2427F9CI

    About Daclatasvir

    Daclatasvir is an orally available inhibitor of the hepatitis C virus (HCV) non-structural protein 5A (NS5A) replication complex, with potential activity against HCV. Although the exact mechanism of action of daclatasvir has yet to be fully determined, this agent, upon oral administration and after intracellular uptake, appears to bind to domain I of the NS5A protein. This inhibits the activity of the NS5A protein and results in the disruption of the viral RNA replication complex, blockage of viral HCV RNA production, and inhibition of viral replication. NS5A, a zinc-binding and proline-rich hydrophilic phosphoprotein, plays a crucial role in HCV RNA replication. HCV is a small, enveloped, single-stranded RNA virus belonging to the Flaviviridae family.

    Daclatasvir Manufacturers

    A Daclatasvir manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Daclatasvir, including repackagers and relabelers. The FDA regulates Daclatasvir manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Daclatasvir API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

    click here to find a list of Daclatasvir manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

    Daclatasvir Suppliers

    A Daclatasvir supplier is an individual or a company that provides Daclatasvir active pharmaceutical ingredient (API) or Daclatasvir finished formulations upon request. The Daclatasvir suppliers may include Daclatasvir API manufacturers, exporters, distributors and traders.

    click here to find a list of Daclatasvir suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

    Daclatasvir USDMF

    A Daclatasvir DMF (Drug Master File) is a document detailing the whole manufacturing process of Daclatasvir active pharmaceutical ingredient (API) in detail. Different forms of Daclatasvir DMFs exist exist since differing nations have different regulations, such as Daclatasvir USDMF, ASMF (EDMF), JDMF, CDMF, etc.

    A Daclatasvir DMF submitted to regulatory agencies in the US is known as a USDMF. Daclatasvir USDMF includes data on Daclatasvir's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Daclatasvir USDMF is kept confidential to protect the manufacturer’s intellectual property.

    click here to find a list of Daclatasvir suppliers with USDMF on PharmaCompass.

    Daclatasvir WC

    A Daclatasvir written confirmation (Daclatasvir WC) is an official document issued by a regulatory agency to a Daclatasvir manufacturer, verifying that the manufacturing facility of a Daclatasvir active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Daclatasvir APIs or Daclatasvir finished pharmaceutical products to another nation, regulatory agencies frequently require a Daclatasvir WC (written confirmation) as part of the regulatory process.

    click here to find a list of Daclatasvir suppliers with Written Confirmation (WC) on PharmaCompass.

    Daclatasvir NDC

    National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Daclatasvir as an active pharmaceutical ingredient (API).

    Finished drug products

    The FDA updates the NDC directory daily. The NDC numbers for Daclatasvir API and other APIs are published in this directory by the FDA.

    Unfinished drugs

    The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

    Pharmaceutical companies that manufacture Daclatasvir as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

    Compounded drug products

    The NDC directory also contains data on finished compounded human drug products that contain Daclatasvir and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Daclatasvir NDC to their finished compounded human drug products, they may choose to do so.

    click here to find a list of Daclatasvir suppliers with NDC on PharmaCompass.

    Daclatasvir GMP

    Daclatasvir Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

    GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

    PharmaCompass offers a list of Daclatasvir GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Daclatasvir GMP manufacturer or Daclatasvir GMP API supplier for your needs.

    Daclatasvir CoA

    A Daclatasvir CoA (Certificate of Analysis) is a formal document that attests to Daclatasvir's compliance with Daclatasvir specifications and serves as a tool for batch-level quality control.

    Daclatasvir CoA mostly includes findings from lab analyses of a specific batch. For each Daclatasvir CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

    Daclatasvir may be tested according to a variety of international standards, such as European Pharmacopoeia (Daclatasvir EP), Daclatasvir JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Daclatasvir USP).

    Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
    For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search